Related Experiment Video
Updated: Jul 6, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer
Flaviana Alves Dos Santos1, Joelson Germano Crispim1, Eduardo Davi Lima da Silva1
1Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil.
Background:
Prostate and pancreatic cancers pose significant global health challenges. This study explored the potential of compound 5b, a novel phthalimido-1,3-thiazole derivative, as an anticancer agent against these malignancies.
Methods:
In vitro, compound 5b exhibited potent cytotoxic activity against both prostate (DU-145 and PC-3) and pancreatic (Panc-1 and Mia Paca-2) cancer cell lines. Notably, it significantly reduced colony formation in PC-3 cells, potentially hindering tumor growth. Furthermore, treatment with compound 5b suppressed cell migration and induced cell cycle arrest in the PC-3 line. Additionally, it triggered cell death through late apoptosis and necrosis at higher concentrations. Safety evaluations in mice revealed no mortality or adverse effects after a 30-day treatment with compound 5b. Key blood parameters (hematology) and biochemical markers of liver and kidney function remained unaltered.
Results:
Compound 5b significantly reduced colony formation, suppressed cell migration, and induced cell cycle arrest and apoptosis/necrosis in prostate cancer cells. In vivo, safety evaluations showed no adverse effects in treated mice, with blood and biochemical markers remaining normal.
Conclusion:
These findings suggest that compound 5b holds promise for further development as a therapeutic option for prostate and pancreatic cancers. Its multimodal activity profile, targeting cell viability, migration, cell cycle progression, and cell death, warrants further investigation.
Insights
Novel compound 5b shows promise as an anticancer agent against prostate and pancreatic cancers. It effectively reduced tumor cell growth, migration, and induced cell death with no observed toxicity in mice.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Prostate and pancreatic cancers represent significant global health burdens.
- Novel therapeutic strategies are urgently needed to combat these malignancies.
Purpose of the Study:
- To investigate the anticancer potential of compound 5b, a novel phthalimido-1,3-thiazole derivative.
- To evaluate the efficacy and safety of compound 5b against prostate and pancreatic cancer models.
Main Methods:
- In vitro cytotoxicity assays against human prostate (DU-145, PC-3) and pancreatic (Panc-1, Mia Paca-2) cancer cell lines.
- Assessment of colony formation, cell migration, cell cycle arrest, apoptosis, and necrosis.
- In vivo safety evaluation in mice, including hematology and liver/kidney function biochemical markers.
Main Results:
- Compound 5b demonstrated potent in vitro cytotoxic activity against both cancer types.
- Significant reduction in colony formation and cell migration, alongside cell cycle arrest and induction of apoptosis/necrosis in PC-3 cells.
- No mortality or adverse effects observed in mice during 30-day treatment; normal blood and biochemical parameters indicated good safety profile.
Conclusions:
- Compound 5b exhibits a promising multimodal activity profile against prostate and pancreatic cancer cells.
- Its ability to target cell viability, migration, cell cycle, and induce cell death warrants further investigation for therapeutic development.
- The favorable safety profile in vivo supports its potential as a future anticancer therapeutic.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
02:38Mitogens and the Cell Cycle
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...